Japan’s focus on precision and quality resonates with our approach to clinical trials, where every detail is designed around better study execution and patient experiences.
Meet StriderDCT at BioJapan 2026 in Yokohama to discover how our AI-enabled digital clinical trial solutions help sponsors make clinical research more patient-centric, efficient, and technology-enabled.
Meet our experts to discuss your upcoming clinical studies and explore how decentralized and hybrid trial models can improve patient participation, streamline clinical operations, and support better-quality data.
BioJapan is Asia’s leading biotechnology partnering event. It brings together an exhibition, seminars, and one-to-one partnering under one roof. This year marks its 40th anniversary, making it the world’s longest-running biotech exhibition. For four decades, BioJapan has connected innovators, researchers, and life science companies from around the world.
We help pharmaceutical companies, biotech organizations, and CROs adopt digital and decentralized clinical trial models that make studies more accessible to patients while improving operational efficiency.
From hybrid studies and virtual visits to fully decentralized trials, we combine technology, clinical operations, and patient engagement to help sponsors execute clinical studies more efficiently and with greater control.
What Makes Us Different?
Looking to make your clinical trials more patient-centric and digitally enabled?
Meet our team at BioJapan 2026 and discuss how StriderDCT can support your upcoming studies.
